MedTrace Logo

A 3-YEAR CLINICAL INVESTIGATION ON THE NOBEL ACTIVE® TIULTRA™ IMPLANT AND ON1™ BASE XEAL1™ _____________________________________________________________

NCT04383834 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 58

Last updated 2020-05-12

No results posted yet for this study

Summary

Soft tissue thickness, using IOS, between implant insertion (baseline) and 3-year follow-up has no changes

Conditions

  • to Study Soft Tissue Health and Stability

Interventions

DEVICE

NobelActive® TiUltra™ implants and On1™ Base/Xeal™ along with On1 components

The NobelActive® TiUltra™ implant is an ultra-hydrophilic multi-zone anodized implant surface. NobelActive® TiUltra™ features a gradual change in topography, from a minimally rough non-porous nanostructured implant collar to a moderately rough porous apex: more than roughness. NobelActive® TiUltra™ collar features surface chemistry and topography that promote early osseointegration and are designed to support bone stability. In addition, the Protective Layer preserves the pristine surface chemistry and hydrophilicity. The second new product is the Base/Xeal™ new surface, which is covered by a titanium oxide layer, created by electrochemical anodization of a titanium machined component, resulting in a yellow hue nano-structured surface.

Sponsors & Collaborators

  • Giacomo Fabbri

    lead NETWORK

Principal Investigators

  • Giacomo Fabbri, Dentist · Studio Ban Mancini Fabbri

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2023-04-01
Completion
2023-05-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04383834 on ClinicalTrials.gov